Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis.
What is next? There are many pathogens, autoimmune diseases, and cancers that may be promising targets for vaccine research and development.
This volume provides an analytic framework and quantitative model for evaluating disease conditions that can be applied by those setting priorities for vaccine development over the coming decades. The committee describes an approach for comparing potential new vaccines based on their impact on morbidity and mortality and on the costs of both health care and vaccine development. The book examines:
The committee provides a way to compare different forms of illness and set vaccine priorities without assigning a monetary value to lives. Their recommendations will be important to anyone involved in science policy and public health planning: policymakers, regulators, health care providers, vaccine manufacturers, and researchers.
Institute of Medicine. 2000. Vaccines for the 21st Century: A Tool for Decisionmaking. Washington, DC: The National Academies Press. https://doi.org/10.17226/5501.
|Progress in Vaccine Development||17-38|
|Considerations of Candidate Vaccines||39-52|
|Overview of Analytic Approach and Results||53-92|
|Review of the Analytical Model||93-108|
|Ethical Considerations and Caveats||109-122|
|Appendix 1: Borrelia burgdorferi||143-148|
|Appendix 2: Chlamydia||149-158|
|Appendix 3: Coccidioides Immitis||159-164|
|Appendix 4: Cytomegalovirus||165-172|
|Appendix 5: Enterotoxigenic E. coli||173-176|
|Appendix 6: Epstein-Barr Virus||177-180|
|Appendix 7: Helicobacter pylori||181-188|
|Appendix 8: Hepatitis C||189-194|
|Appendix 9: Herpes Simplex Virus||195-206|
|Appendix 10: Histoplasma capsulatum||207-212|
|Appendix 11: Human Paillomavirus||213-222|
|Appendix 12: Influenza A and B||223-232|
|Appendix 13: Insulin-Dependent Diabetes Mellitus||233-238|
|Appendix 14: Melanoma||239-244|
|Appendix 15: Multiple Sclerosis||245-250|
|Appendix 16: Mycobacterium tuberculosis||251-256|
|Appendix 17: Neisseria gonnorrhea||257-266|
|Appendix 18: Neisseria meningitidis||267-272|
|Appendix 19: Parainfluenza Virus||273-278|
|Appendix 20: Respiratory Syncytial Virus||279-284|
|Appendix 21: Rheumatoid Arthritis||285-290|
|Appendix 22: Rotavirus||291-294|
|Appendix 23: Shigella||295-298|
|Appendix 24: Streptococcus, Group A||299-304|
|Appendix 25: Streptococcus, Group B||305-312|
|Appendix 26: Streptococcus pneumoniae||313-322|
|Appendix 27: Information on accessing Electronic Spreadsheets||323-324|
|Appendix 28: Summary of Workshops||325-434|
|Appendix 29: Questions Posed to Outside Experts and List of Responders||435-442|
The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, pleaseclick here to view more information.